- Aeglea BioTherapeutics (NASDAQ:AGLE): Q2 EPS of -$0.47 beats by $0.01.
- Revenue of $1.48M (+8.0% Y/Y) beats by $0.19M.
- Press Release
Aeglea BioTherapeutics beats by $0.01, beats on revenue
Recommended For You
More Trending News
About SYRE Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SYRE | - | - |
Spyre Therapeutics, Inc. |